Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children
Abstract Background Hypophosphatasia (HPP) is a rare, inherited metabolic disorder caused by loss-of-function mutations in the ALPL gene that encodes the tissue-nonspecific alkaline phosphatase TNAP (ORPHA 436). Its clinical presentation is highly heterogeneous with a remarkably wide-ranging severit...
Main Authors: | Marius Vogt, Hermann Girschick, Tilmann Schweitzer, Clemens Benoit, Annette Holl-Wieden, Lothar Seefried, Franz Jakob, Christine Hofmann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01500-x |
Similar Items
-
Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy
by: Bowden SA, et al.
Published: (2018-09-01) -
Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
by: Orimo H
Published: (2016-05-01) -
Hypophosphatasia: from birth to adulthood
by: Fernanda Salles Reis, et al.
Published: (2023-06-01) -
Childhood hypophosphatasia: to treat or not to treat
by: Eric T. Rush
Published: (2018-07-01) -
Clinical application experience of asfotase alfa for a young patient with childhood hypophosphatasia
by: Nataliya Y. Kalinchenko, et al.
Published: (2019-11-01)